FGFR2 translocation
|
Cholangiocarcinoma
|
FGFR2 translocation
|
Cholangiocarcinoma
|
pemigatinib Sensitive: C2 – Inclusion Criteria
|
pemigatinib Sensitive: C2 – Inclusion Criteria
|
FGFR2 translocation
|
Cholangiocarcinoma
|
FGFR2 translocation
|
Cholangiocarcinoma
|
ICP-192 Sensitive: C3 – Early Trials
|
ICP-192 Sensitive: C3 – Early Trials
|